GBLX

GB Sciences, Inc. GBLX

GBLX
GB Sciences, Inc. IRBS
IR Biosciences Holdings Inc. GSTC
GlobeStar Therapeutics Corporation BIOAF
Bioasis Technologies Inc. EHOS
Ehouse Global, Inc. RGMP
Regnum Corp. ACUS
Acusphere, Inc. PBLA
Panbela Therapeutics, Inc. HTDS
Hard to Treat Diseases Inc. TSTS
That Marketing Solution, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GBLX IRBS GSTC BIOAF EHOS RGMP ACUS PBLA HTDS TSTS
6M 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -99.87 % 0.00 % 0.00 %
YTD -93.33 % 0.00 % -75.00 % 100.00 % 900.00 % 0.00 % 0.00 % -99.93 % 1 900.00 % 0.00 %
1Y -92.50 % 0.00 % -66.67 % 100.00 % 900.00 % 0.00 % 0.00 % -99.91 % 100.00 % 0.00 %
3Y -98.56 % 5 900.00 % -99.17 % -99.47 % -90.00 % -99.93 % 0.00 % -100.00 % 100.00 % 900.00 %
5Y -99.30 % 5 900.00 % -98.46 % -99.92 % 49 900.00 % -99.98 % -99.97 % -100.00 % 100.00 % -98.00 %
10Y -99.82 % 5 900.00 % -99.95 % -99.98 % 9 999 900.00 % -99.93 % -99.98 % -100.00 % -80.00 % -99.47 %
From the beginning -100.00 % 5 900.00 % -99.96 % -99.97 % -66.67 % -99.93 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend